Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/301333 stock hub

SHE/301333 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301333is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.9B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301333

In the news

Latest news · SHE/301333

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E35.4

P25 17.1P50 24.2P75 37.8

Trailing P/E43.6

P25 23.5P50 41.3P75 83.2

ROE7

P25 -0.9P50 4.1P75 8.8

ROIC38.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301333 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

CNY

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,645
Employees Change	437%
Employees Change Percent	19.79
Enterprise value	CNY 4.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100005K44
Last refreshed	2026-05-10
Market cap	CNY 5.9B
Price	CNY 61.16
Price currency	CNY
Rev Per Employee	338,849.6x
Sector	Healthcare
Sic	8731
Symbol	she/301333
Website	https://www.rg-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.28%
EV Earnings	31.44x
EV/EBIT	33.7x
EV/EBITDA	29.83x
EV/FCF	47.47x
EV/Sales	4.69x
FCF yield	1.51%
Forward P/E	35.35x
P/B ratio	2.93x
P/E ratio	43.64x
P/S ratio	6.55x
PE Ratio3 Y	36.36x
PE Ratio5 Y	38.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.91%
EBITDA Margin	14.21%
FCF margin	9.88%
Gross margin	33.29%
Gross Profit	CNY 298.4M
Gross Profit Growth	9.71%
Gross Profit Growth Q	4.29%
Gross Profit Growth3 Y	9.21%
Gross Profit Growth5 Y	36.44%
Net Income	CNY 133.7M
Net Income Growth	-6.7%
Net Income Growth Q	-12.46%
Net Income Growth3 Y	4.99%
Net Income Growth5 Y	41.4%
Pretax Margin	16.93%
Profit Margin	14.91%
Profit Per Employee	CNY 50,530
ROA	3.33
Roa5y	5.44
ROCE	6.11
ROE	6.96
Roe5y	12.4
ROIC	38.63
Roic5y	114.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	34.77%
Cagr3y	-0.94%
EPS Growth	-6.55
EPS Growth Q	-11.11
EPS Growth3 Y	2.24
EPS Growth5 Y	33.43
FCF Growth	-11.07%
FCF Growth3 Y	-11.02%
FCF Growth5 Y	41.82%
OCF Growth	-10.77%
OCF Growth3 Y	-9.35%
OCF Growth5 Y	43.82%
Revenue Growth	21.2x
Revenue Growth Q	26.18x
Revenue Growth3 Y	12.58x
Revenue Growth5 Y	44.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.38
Assets	CNY 2.4B
Cash	CNY 1.7B
Current Assets	CNY 2.2B
Current Liabilities	CNY 359.5M
Debt	CNY 42.5M
Debt EBITDA	CNY 0.3
Debt Equity	CNY 0.02
Debt FCF	CNY 0.48
Equity	CNY 2B
Interest Coverage	43.52
Liabilities	CNY 397.6M
Long Term Assets	CNY 239.7M
Long Term Liabilities	CNY 38.1M
Net Cash	CNY 1.7B
Net Cash By Market Cap	CNY 28.56
Net Cash Growth	-1.43%
Net Debt EBITDA	CNY -13.16
Net Debt Equity	CNY -0.84
Net Debt FCF	CNY -18.94
Tangible Book Value	CNY 1.9B
Tangible Book Value Per Share	CNY 19.93
WACC	7.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.01
Inventory Turnover	9.47
Net Working Capital	CNY 118.7M
Quick ratio	5.83
Working Capital	CNY 1.8B
Working Capital Turnover	CNY 0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.16%
Dividend Growth	-20%
Dividend Growth Years	0%
Dividend per share	CNY 0.16
Dividend Years	3
Dividend Yield	0.26%
Ex Div Date	2025-07-08
Last Dividend	CNY 0.16
Payout Frequency	Annual
Payout Ratio	12.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	34.74%
200-day SMA	61.14
3Y total return	-2.79%
50-day SMA	65.81
50-day SMA vs 200-day SMA	50over200
All Time High	91.78
All Time High Change	-33.36%
All Time High Date	2026-01-14
All Time Low	33.05
All Time Low Change	85.05%
All Time Low Date	2024-07-05
ATR	2.85
Beta	0.52
Beta1y	0.55
Beta2y	0.8
Ch YTD	2.7
High	61.62
High52	91.78
High52 Date	2026-01-14
High52ch	-33.36%
Low	60.3
Low52	43.05
Low52 Date	2025-05-19
Low52ch	42.07%
Ma50ch	-7.06%
Price vs 200-day SMA	0.04%
RSI	38.09
RSI Monthly	52.27
RSI Weekly	47.06
Sharpe ratio	0.77x
Sortino ratio	1.48
Total Return	0.42%
Tr YTD	2.7
Tr1m	-7.19%
Tr1w	-0.15%
Tr3m	-22.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 124.7M
Operating Income Growth	-0.84
Operating Income Growth Q	17.89
Operating Income Growth3 Y	8.15
Operating Income Growth5 Y	35.53
Operating margin	13.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,412,454%
Net Borrowing	-13,865,860
Shares Insiders	12.32%
Shares Institutions	14.42%
Shares Out	95,991,256
Shares Qo Q	-1.17%
Shares Yo Y	-0.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 88.5M
Average Volume	1,727,532.45x
Bv Per Share	20.99
CAPEX	CNY -18.8M
Ch1m	-7.19
Ch1w	-0.15
Ch1y	34.3
Ch3m	-22.62
Ch3y	-3.97
Ch6m	-3.56
Change	-1%
Change From Open	-0.71
Close	61.78
Days Gap	-0.29
Depreciation Amortization	2,678,186
Dollar Volume	65,207,568.8
Earnings Date	2026-04-28
EBIT	CNY 124.7M
EBITDA	CNY 127.4M
EPS	CNY 1.4
F Score	5
FCF	CNY 88.5M
FCF EV Yield	2.11x
FCF Per Share	CNY 0.92
Financing CF	-32,117,791
Fiscal Year End	December
Founded	2,008
Goodwill	85,601,229
Graham Number	25.72665
Graham Upside	-57.94
Income Tax	CNY 17M
Investing CF	305,240,258
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2023-06-29
Last Split Type	Forward
Lynch Fair Value	CNY 35.04
Lynch Upside	-42.71
Ma150	63.1
Ma150ch	-3.07%
Ma20	66.4
Ma20ch	-7.89%
Net CF	374,062,312
Next Earnings Date	2026-08-28
Open	61.6
P FCF Ratio	66.32
P OCF Ratio	54.71
Payment Date	2025-07-08
Position In Range	65.15
Ppne	47,167,235
Price Date	2026-05-08
Price EBITDA	CNY 46.1
Ptbv Ratio	3.1
Relative Volume	0.62x
Revenue	896,257,181x
Tax By Revenue	1.89x
Tax Rate	11.18%
Tr6m	-3.56%
Volume	1,066,180

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301333 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$0.16 annual per share

Payout ratio

+12.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2025-07-08

Performance

SHE/301333 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301333?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.4%

Share of float held by funds and institutions

Insider ownership

+12.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

SHE/301333 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.1

Neutral momentum band

Price vs 200-day MA

+0.0%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301333

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301333 stock rating?

she/301333 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301333 analysis?

The full report lives at /stocks/she/301333/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301333?

The latest report frames she/301333 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301333 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.